Brosious E M, Wright J M, Baine R M, Schmidt R M
Clin Chem. 1978 Dec;24(12):2196-9.
On 20 consecutive work days during four weeks, one technologist performed 24 microchromatographic determinations of hemoglobin A2 (Hb A2) by each of four methods: the Efremov procedure requiring Tris/HCl buffer, the original Huisman technique with use of glycine developer, and two commercial test kits in which a modified glycine developer is used. The bloood samples tested were obtained from 12 adults with no hematological abnormality and from 12 beta-thalassemia carriers previously diagnosed by familial and hematologic studies. Results by the first method and the two commercial kits (one from Helena Laboratories and one from Isolab, Inc.) did not differ significantly in precision for either the normal or beta-thalassemia trait samples. For both sample types, the second method yielded larger coefficients of variation than those obtained with the other methods. Moreover, the second method was the only one with which values overlapped for normal samples and samples with above-normal Hb A2 concentrations.
在四周内连续20个工作日中,一名技术人员使用四种方法中的每种方法对血红蛋白A2(Hb A2)进行了24次微量色谱测定:需要Tris/HCl缓冲液的叶夫列莫夫方法、使用甘氨酸显影剂的原始休斯曼技术以及两种使用改良甘氨酸显影剂的商业检测试剂盒。所检测的血液样本取自12名无血液学异常的成年人以及12名先前经家族和血液学研究确诊的β地中海贫血携带者。对于正常样本或β地中海贫血特征样本,第一种方法和两种商业试剂盒(一种来自海伦娜实验室,一种来自伊索实验室公司)的精密度没有显著差异。对于这两种样本类型,第二种方法产生的变异系数比其他方法获得的变异系数更大。此外,第二种方法是唯一一种正常样本和Hb A2浓度高于正常的样本值出现重叠的方法。